Houston-based mental health startup backed by Serena Williams emerges from stealth

smart counseling

OURS is re-imagining and de-stigmatizing couples therapy. Photo by Mikhail Nilov/Pexels

A Houston startup that's re-imagining mental health treatment and counseling has emerged from stealth, announcing financial support from seed investors including tennis legend and venture capital investor Serena Williams.

Targeting the $5 trillion health and wellness market, OURS is founded by family therapist and author Liz Earnshaw, as well as Adam Putterman and Jessica Holton.

“We’re excited to take this first step in shifting the way we think about relationship health. We are building for a world that treats relationship health with equal importance as physical, mental and emotional health. We want working on your relationships to be an everyday experience, accessible to all,” says Holton, who serves as co-CEO, in a news release.

The company has raised nearly $5 million pre-seed and seed round from investors including TMV, Serena Ventures, Lakehouse Ventures, Collaborative Fund, GreyMatter, and pioneering angel investors such as Andy Dunn.

“Research shows that relationships are the most important factor to our overall health and wellbeing, which is an area that I'm hyper-focused on in my personal life,” says Williams, managing partner of San Francisco-based Serena Ventures, in the release. “When I learned about what the team was doing, I knew this was something we needed to support.

"OURS offers a reimagined and preventative solution to relationship wellness that's not only experiential and research-backed, but memorable and fun," she continues. "We're proud to be early investors in a brand that is making relationship health accessible to couples everywhere and play an integral part of the larger OURS mission.”

OURS has thousands of couples already using its platform. Image via OURS

The company launched its beta in 2020 and has already worked with thousands of customers and has an engaged community of couples across its platforms.

The OURS founders were inspired by their own experiences with couples counseling and created a technology-enabled platform based of expert and data-backed research.

“As it stands, the current mental health and wellness space is largely geared towards individuals, yet nearly 50 percent of couples have either participated in, or have sought out solutions, to foster stronger romantic partnerships,” says Soraya Darabi, co-founder and general partner at TMV, in the release. “However, a lack of therapists - until now - or confused perception of couples counseling leave needs unmet.”

Initially targeting romantic partners, the platform costs $400 for a four-week program that includes six personalized interactive sessions with an OURS guide at the helm of the experience. These one-hour technology-powered sessions are based around an innovative new technology, called Loveware, and include dynamic and meaningful conversations between a couple that are built around the magic that comes from being in the room with an expert.

From Your Site Articles
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

TMC lands $3M grant to launch cancer device accelerator

cancer funding

A new business accelerator at Houston’s Texas Medical Center has received a nearly $3 million grant from the Cancer Prevention and Research Institute of Texas.

The CPRIT grant, awarded to the Texas Medical Center Foundation, will help launch the Accelerator for Cancer Medical Devices. The accelerator will support emerging innovators in developing prototypes for cancer-related medical devices and advancing them from prototype to clinical trials.

“The translation of new cancer-focused precision medical devices, often the width of a human hair, creates the opportunity to develop novel treatments for cancer patients,” the accelerator posted on the CPRIT website.

Scientist, consultant, and entrepreneur Jason Sakamoto, associate director of the TMC Center for Device Innovation, will oversee the accelerator. TMC officials say the accelerator builds on the success of TMC Innovation’s Accelerator for Cancer Therapeutics.

Each participant in the Accelerator for Cancer Medical Devices program will graduate with a device prototype, a business plan, and a “solid foundation” in preclinical and clinical strategies, TMC says. Participants will benefit from “robust support” provided by the TMC ecosystem, according to the medical center, and “will foster innovation into impactful and life-changing cancer patient solutions in Texas and beyond.”

In all, CPRIT recently awarded $27 million in grants for cancer research. That includes $18 million to attract top cancer researchers to Texas. Houston institutions received $4 million for recruitment:

  • $2 million to the University of Texas MD Anderson Cancer Center to recruit Rodrigo Romero from Memorial Sloan Kettering Cancer Center in New York City
  • $2 million to MD Anderson to recruit Eric Gardner from Weill Cornell Medicine in New York City

A $1 million grant also went to Baylor College of Medicine researcher Dr. Akiva Diamond. He is an assistant professor at the medical college and is affiliated with Baylor’s Dan L. Duncan Comprehensive Cancer Center.

Musk’s SpaceX spends $17B to acquire spectrum licenses from EchoStar

SpaceX Update

Elon Musk’s SpaceX has reached a deal worth about $17 billion with EchoStar for spectrum licenses that it will use to beef up its Starlink satellite network.

The deal for EchoStar’s AWS-4 and H-block spectrum licenses includes up to $8.5 billion in cash and up to $8.5 billion in SpaceX stock. SpaceX will make approximately $2 billion in cash interest payments on EchoStar debt through November 2027.

SpaceX and EchoStar will enter into a long-term commercial agreement which will allow EchoStar’s Boost Mobile subscribers to access SpaceX’s next generation Starlink Direct to Cell service.

Shares of EchoStar surged 19% before the market opened Monday.

Last month AT&T said that it will spend $23 billion to acquire wireless spectrum licenses from EchoStar, a significant expansion of its low- and mid-band coverage networks.

EchoStar said that it anticipates that the AT&T deal and the SpaceX transaction will resolve recent inquiries from the Federal Communications Commission about the rollout of 5G technology in the U.S. The FCC had been calling for hearings on whether Echostar was properly using the spectrum that it is now selling, and its efforts to make 5G more available to communities.

EchoStar said Monday that it will use the proceeds from the sale partly to pay down debt. Current operations of Dish TV, Sling and Hughes will not be impacted, the company said.

Houston students develop cost-effective glove to treat Parkinson's symptoms

smart glove

Two Rice undergraduate engineering students have developed a non-invasive vibrotactile glove that aims to alleviate the symptoms of Parkinson’s disease through therapeutic vibrations.

Emmie Casey and Tomi Kuye developed the project with support from the Oshman Engineering Design Kitchen (OEDK) and guidance from its director, Maria Oden, and Rice lecturer Heather Bisesti, according to a news release from the university.

The team based the design on research from the Peter Tass Lab at Stanford University, which explored how randomized vibratory stimuli delivered to the fingertips could help rewire misfiring neurons in the brain—a key component of Parkinson’s disease.

Clinical trials from Stanford showed that coordinated reset stimulation from the vibrations helped patients regain motor control and reduced abnormal brain activity. The effects lasted even after users removed the vibrotactile gloves.

Casey and Kuye set out to replicate the breakthrough at a lower cost. Their prototype replaced the expensive motors used in previous designs with motors found in smartphones that create similar tiny vibrations. They then embedded the motors into each fingertip of a wireless glove.

“We wanted to take this breakthrough and make it accessible to people who would never be able to afford an expensive medical device,” Casey said in the release. “We set out to design a glove that delivers the same therapeutic vibrations but at a fraction of the cost.”

Rice’s design also targets the root of the neurological disruption and attempts to retrain the brain. An early prototype was given to a family friend who had an early onset of the disease. According to anecdotal data from Rice, after six months of regularly using the gloves, the user was able to walk unaided.

“We’re not claiming it’s a cure,” Kuye said in the release. “But if it can give people just a little more control, a little more freedom, that’s life-changing.”

Casey and Kuye are working to develop a commercial version of the glove priced at $250. They are taking preorders and hope to release 500 pairs of gloves this fall. They've also published an open-source instruction manual online for others who want to try to build their own glove at home. They have also formed a nonprofit and plan to use a sliding scale price model to help users manage the cost.

“This project exemplifies what we strive for at the OEDK — empowering students to translate cutting-edge research into real-world solutions,” Oden added in the release. “Emmie and Tomi have shown extraordinary initiative and empathy in developing a device that could bring meaningful relief to people living with Parkinson’s, no matter their resources.”

View All Listings